Health Care & Life Sciences » Biotechnology | China Regenerative Medicine International Ltd.

China Regenerative Medicine International Ltd. | Mutual Funds

Mutual Funds that own China Regenerative Medicine International Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
iShares Plc - Core MSCI Emerging Markets IMI UCITS ETF
18,685,000
0.11%
0
0%
09/05/2018
iShares III Plc - MSCI Emerging Markets Small Cap
7,215,000
0.04%
0
0.04%
09/05/2018
CREF Stock Account
6,650,000
0.04%
0
0%
03/31/2018
SPDR S&P International Small Cap ETF
6,093,056
0.04%
0
0.01%
09/06/2018
iShares MSCI Emerging Markets Small Cap ETF
5,135,000
0.03%
0
0.04%
09/05/2018
SPDR S&P World (ex-US) ETF
5,075,000
0.03%
20,000
0%
09/06/2018
Eaton Vance Parametric Structured International Equity Fund
3,140,000
0.02%
0
0.03%
06/30/2018
iShares MSCI China Small Cap ETF
2,530,000
0.01%
0
0.2%
09/06/2018
iShares II Plc - MSCI AC Far East (ex-Japan) Small Cap
1,375,000
0.01%
0
0.05%
09/05/2018
Eaton Vance Tax Managed International Equity Portfolio
1,025,000
0.01%
0
0.03%
06/30/2018

About China Regenerative Medicine International

View Profile
Address
Rooms 3006-10, 30/F
Hong Kong
Hong Kong
Employees -
Website http://www.crmi.hk
Updated 07/08/2019
China Regenerative Medicine International Ltd. is an investment holding company, which engages in in research and development, production and sales of tissue engineering and regenerative medicine products. It operates through the following business segments: Tissue Engineering, Cell, and Cosmetic and Others, and Medical Equipment. The Tissue Engineering segment produces and sells tissue.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.